Omicron-specific mRNA-based booster vaccine gets DCGI nod
New Delhi: The Department of Biotechnology (DBT) on Tuesday announced that the Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology by Gennova Biopharmaceuticals has got a nod from the office of the Drug Control General of India (DCGI) for Emergency Use Authorization (EUA).…